
Thoracic, Trauma & Foregut Surgery @CIUSSSNMTL & @McGillU, Chief of Thoracic @ Sacré-Coeur Hospit, Assist Professor @UMontreal, Alum @Stanford
Montréal, Québec
Joined December 2011
- Tweets839
- Following990
- Followers605
- Likes950
Last wk to apply! Come spend a yr with us in beautiful Montreal honing your expertise in UpperGI and Thoracic Surgery. Great opportunity with my amazing colleagues! @DoctorJSpicer @JonathanCools @sara_najmeh @LFerri123 mcgill.ca/thoracic/fellowshi…
Mathieu Rousseau retweeted
The VALUE Trial team shows that same-day discharge after VATS lung resection can be done safely for carefully selected patients.
Strong work from @DoctorJSpicer, @MThoracics, @LyndonCWalsh, @filippog92 & @MeravRokah 👏.
In LuCE’s 5th Report, 6 in 10 people said family life was heavily affected by #lungcancer - time away from loved ones adds to the challenge.
📄 Spicer et al., JTCVS 2025
🔗 sciencedirect.com/science/ar…
#ThoracicSurgery #LCSM
Mathieu Rousseau retweeted
Super proud of our team @MThoracics for putting together this trial showing that same day discharge after lung resection, specifically anatomic lung resection, is both safe and feasible! Would not have been possible without the hard work of @LyndonCWalsh and @MeravRokah, as well as our nurses Erin Cronin and Tia Wallace. @sara_najmeh is now leading our standard of care pathway implementation! sciencedirect.com/science/ar…
Mathieu Rousseau retweeted
Come to beautiful Montreal for outstanding fellowships in both upper GI surgery and advanced thoracic surgery.
Are you a general or thoracic surgeon looking to develop your skills with a world-class team of thoracic surgeons? Less than 1mo to submit application to our fellowship program for position starting July 2026. @DoctorJSpicer @LFerri123 mcgill.ca/thoracic/fellowshi…
Are you a general or thoracic surgeon looking to develop your skills with a world-class team of thoracic surgeons? Less than 1mo to submit application to our fellowship program for position starting July 2026. @DoctorJSpicer @LFerri123 mcgill.ca/thoracic/fellowshi…
Mathieu Rousseau retweeted
Replying to @DoctorJSpicer
@DoctorJSpicer just articulated what I think has been the theme of the paradigm changing work presented at #ASCO24, “It’s more about disease biology than the anatomical extent.” This is absolutely how I am beginning to think about lung cancer—staging is not a complete prognostic indicator.
Mathieu Rousseau retweeted
ESOPEC trial
It’s been a long 15 year journey, but so nice to see Docetaxel triplets come on top for the benefit of our patients!
CROSS just doesn’t work for GEA-EAC- radiation compensates for poor surgical control (trans-hiatal) and CM577 compensates for poor systemic control
Mathieu Rousseau retweeted
🚨🚨🚨 #ESOPEC🚨🚨🚨
🔥Practice shifting trial🔥
Patients with resectable, locally advanced, esophagus/GEJ adenocarcinoma
Randomized
Peri-op FLOT (FLOT4)
vs
Pre-operative chemoradiation (CROSS)
Congrats to the study investigators!
Let’s dive in!
#ASCO24 @MayoRadOnc
1/
Mathieu Rousseau retweeted
New from the Plenary Session at #ASCO24: ESOPEC helps settle debate on superiority of perioperative #chemo (FLOT) vs neoadjuvant chemoradiotherapy (CROSS) in esophageal cancer with 29-month improvement in OS with FLOT vs CROSS: brnw.ch/21wKmPS #ASCODailyNews #esocsm
Mathieu Rousseau retweeted
«De garde 24/7» vous revient pour une 9e saison dans de tous nouveaux lieux. Découvrez les équipes de l'hôpital Sacré-Coeur de Montréal, l'hôpital Le Royer de Baie-Comeau et de l'EVAQ.
📺Jeudi 20h, dès le 7 septembre
👉youtu.be/4pi4aFDfjjo
Mathieu Rousseau retweeted
After 4 years of preparation, finally able to provide surgical care to our Inuit patient population within their communities. Sixteen satisfied patients treated this week who did not have to travel 1600km to Montreal for their surgeries. #Puvirnituq
Protocol and human error to blame, not ‘inability’ to treat rape victim in French cultmtl.com/2023/07/protocol… via @Crunchify – at Bromont, Québec
435
36 000 ppl at @ASCO. Impressive plenary with @Surgeon_General.
1
545
That’s why I tell my patients Lung Cancer is the new Breast Cancer. @ASCO That’s where we are going too!
3
691
Amazing talk by @DrMarkAwad @ASCO
Cross trials comparisons of peri-op IO. Neoadj seems advantageous.
The ❔remains,what to do with poor path responders?
Frequent discussion at our TB, data is badly needed.
Didn’t bring up radiation as an option for persistent N2. Thoughts?
446
Mathieu Rousseau retweeted
EFS subgroup analyses below
▪️👆PD-L1 % = 👆 benefit (unlike PEARLS)
▪️EGFR & ALK enrolled (but limited #)
#ASCO23 #lcsm @LungCancerRx
Interesting surgical results from KN671 @ASCO by @HwakeleeMD
Pembro/Cx group:
18% did not make it to surgery (similar to CM816)
92% R0
18% pCR/30% MPR
EFR HR 0.58 (mEFR not reached vs 17mo)
Importantly, benefit across all responders (not just cPR/MPR)
@DoctorJSpicer
Mathieu Rousseau retweeted
Record attendance of 1️⃣1️⃣0️⃣ for Toronto NET regional conference!🦓 Thanks to incredible speakers and engaged attendees who travelled from near & far, and to dedicated @NANETS1 staff! Beyond amazing to have had so many people together to talk about & advance the care of #NETs in🇨🇦 🙏
See you all in Montreal for #NANETS23!
@AmanChauhanMD @JaydiDelRivero @DrCNClarke @AGangiMD @RousseauMC @NadineMallak – at Toronto, Ontario
































